Featured Videos #1

Prescribing to reduce further events in chronic coronary syndrome and cardiac failure

15 January 2025

Gayle Campbell and Professor Pardeep Jhund discuss secondary prevention for heart failure patients, including key topics such as preventing reinfarction, foundational anti-failure agents, managing worsening heart failure, and improving patient adherence using tools like MedTap.

Cardiac inflammation: the fire within

18 December 2024

Federica Marelli-Berg takes a look at some common and not-so-common causes of myocarditis, and the clinical manifestations cardiologists should consider.

ESC Congress 2024 highlights – A UK perspective: What’s new in the latest ESC guideline update?

12 December 2024

Dr Paul Foley and Prof Terry McCormack share the key changes in the new ESC guidance on atrial fibrillation, hypertension and arterial disease.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

ESC Congress 2024 highlights – A UK perspective: New evidence on cardiovascular medical care

12 December 2024

Dr Sarah Birkhoelzer and Dr Aaron Henry discuss hot topics and late-breaking abstracts from across the congress.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

Masterclass: Lipoprotein(a) – a suitable case for treatment?

10 December 2024

In this masterclass, Dr Dermot Neely and Dr Jai Cegla discuss the why, when and how of measuring lipoprotein(a) [Lp(a)], the current management of people with elevated Lp(a) and the future prospects for treatment.

Transcatheter cardiac valves: An update in 2024

29 November 2024

Jon Byrne and Madalina Garbi explore the latest guidelines and current practice around transcatheter valve interventions (including aortic valve implantation (TAVI), mitral regurgitation management and tricuspid valve repair) – which patients are suitable for these interventions, and how do they compare to traditional surgical approaches?

Treatments to improve cardiorenal outcomes in CKD. ‘Known knowns and known unknowns’

10 October 2024

Boehringer Ingelheim and Lilly Alliance has provided funding towards this educational programme. The Alliance has had no editorial input or influence on the agenda, collateral content of this meeting including the selection of speakers.

Cardiorenal changes in later life

10 October 2024

This webinar has been sponsored by A Menarini Pharmaceuticals Ireland and A. Menarini Farmaceutica Internazionale SRL who have had no input into the topics discussed or selection of speakers.

Pitfalls in heart failure – Digoxin toxicity in the elderly

9 September 2024

Watch this informative video short, featuring Dr Paul Andrews as he describes some of the pitfalls of digoxin use within the elderly population and explores ways to minimise the risks and correctly identify when to take action to treat potentially life threatening scenarios.

Masterclass: Treating dyslipidaemia – special populations

8 August 2024

In this masterclass, Alison Pottle and Jai Cegla provide discuss screening for familial hypercholesterolaemia (FH), treatment advances in dyslipidaemia, the role of lipid apheresis in specific populations and the importance of patient education.